<?xml version="1.0" encoding="UTF-8"?><rss version="2.0" xmlns:content="http://purl.org/rss/1.0/modules/content/"><channel><title>同写意 | wechat-feeds</title><link>http://MzA4MzgzMDM5Mg.favicon.privacyhide.com/favicon.ico</link><description>一个以新药创制为核心，汇集国内一流研发精英的大型交流与价值分享平台。“同筑技术人生路，写意中国新药魂”是同写意的初衷与愿景。秉承汇集“一线、一流”，讲求“实用、实在、时效”的原则。</description><managingEditor> (hellodword)</managingEditor><pubDate>Sat, 17 Apr 2021 21:27:06 +0800</pubDate><image><url>http://MzA4MzgzMDM5Mg.favicon.privacyhide.com/favicon.ico</url><title>同写意 | wechat-feeds</title><link>http://MzA4MzgzMDM5Mg.favicon.privacyhide.com/favicon.ico</link><width>64</width><height>64</height></image><item><title>写意报告丨PD-1/PD-L1相关药物发明的专利保护</title><link>https://mp.weixin.qq.com/s/AF5t7HQUD2bKIwcK4VJVSQ</link><description></description><content:encoded><![CDATA[写意报告丨PD-1/PD-L1相关药物发明的专利保护]]></content:encoded><pubDate>Sat, 17 Apr 2021 19:42:46 +0800</pubDate></item><item><title>博腾生物完成A轮融资，加速布局基因与细胞治疗CDMO商业化生产</title><link>https://mp.weixin.qq.com/s/vG_mv1pEXptUjSVPDs6ETw</link><description></description><content:encoded><![CDATA[博腾生物完成A轮融资，加速布局基因与细胞治疗CDMO商业化生产]]></content:encoded><pubDate>Sat, 17 Apr 2021 19:42:46 +0800</pubDate></item><item><title>关注杜丨胃癌治疗新突破，首款联合免疫疗法获FDA批准</title><link>https://mp.weixin.qq.com/s/NRzuoX_xYpD1fHJDYEQ3Mw</link><description></description><content:encoded><![CDATA[关注杜丨胃癌治疗新突破，首款联合免疫疗法获FDA批准]]></content:encoded><pubDate>Sat, 17 Apr 2021 19:42:46 +0800</pubDate></item><item><title>论持久战：Theseus肿瘤全程用药战略</title><link>https://mp.weixin.qq.com/s/MtR7BXm6oVEO5DNFymYo-A</link><description></description><content:encoded><![CDATA[论持久战：Theseus肿瘤全程用药战略]]></content:encoded><pubDate>Sat, 17 Apr 2021 19:42:46 +0800</pubDate></item><item><title>写意报告︱董增军：打造生物医药创新创业生态圈</title><link>https://mp.weixin.qq.com/s/erUaUnGJjuxsyr3VJx8fAg</link><description></description><content:encoded><![CDATA[写意报告︱董增军：打造生物医药创新创业生态圈]]></content:encoded><pubDate>Fri, 16 Apr 2021 19:05:01 +0800</pubDate></item><item><title>开拓药业福瑞他恩治疗痤疮I/II期临床试验完成首批受试者给药</title><link>https://mp.weixin.qq.com/s/NmlEtHyZzNT_UXpn2TA4HA</link><description></description><content:encoded><![CDATA[开拓药业福瑞他恩治疗痤疮I/II期临床试验完成首批受试者给药]]></content:encoded><pubDate>Fri, 16 Apr 2021 19:05:01 +0800</pubDate></item><item><title>2021太湖湾生命健康未来大会丨创新医药和智慧医疗会议</title><link>https://mp.weixin.qq.com/s/US4WIXpvU4Wc7YrYn39mhg</link><description></description><content:encoded><![CDATA[2021太湖湾生命健康未来大会丨创新医药和智慧医疗会议]]></content:encoded><pubDate>Fri, 16 Apr 2021 19:05:01 +0800</pubDate></item><item><title>药物制剂元素杂质控制该如何做？</title><link>https://mp.weixin.qq.com/s/6bevzjG1QFNqzi4uIXVh_Q</link><description></description><content:encoded><![CDATA[药物制剂元素杂质控制该如何做？]]></content:encoded><pubDate>Fri, 16 Apr 2021 19:05:01 +0800</pubDate></item><item><title>AACR：细胞因子新时代</title><link>https://mp.weixin.qq.com/s/OkSNdQvDL4uwVEaUtMPTJg</link><description></description><content:encoded><![CDATA[AACR：细胞因子新时代]]></content:encoded><pubDate>Fri, 16 Apr 2021 19:05:01 +0800</pubDate></item><item><title>CRO并购与全球化之路如何走？</title><link>https://mp.weixin.qq.com/s/nqTUu9KzJWvZNfzuwKLGQw</link><description></description><content:encoded><![CDATA[CRO并购与全球化之路如何走？]]></content:encoded><pubDate>Thu, 15 Apr 2021 21:21:29 +0800</pubDate></item><item><title>阿诺医药宣布Buparlisib（AN2025）治疗复发性或转移性头颈癌的全球III期临床完成首例患者给药</title><link>https://mp.weixin.qq.com/s/Akv_ci_3RWNMSCS11Mvcbg</link><description></description><content:encoded><![CDATA[阿诺医药宣布Buparlisib（AN2025）治疗复发性或转移性头颈癌的全球III期临床完成首例患者给药]]></content:encoded><pubDate>Thu, 15 Apr 2021 21:21:29 +0800</pubDate></item><item><title>中国医药设备工程协会批准成立生物制药工程专业委员会</title><link>https://mp.weixin.qq.com/s/iayeOEMXnBOKzHKpQN5WBA</link><description></description><content:encoded><![CDATA[中国医药设备工程协会批准成立生物制药工程专业委员会]]></content:encoded><pubDate>Thu, 15 Apr 2021 21:21:29 +0800</pubDate></item><item><title>150亿美元大手笔！赛默飞世尔将收购CRO巨头PPD</title><link>https://mp.weixin.qq.com/s/jJ8Tcymhmkb3DWTtOruXEg</link><description></description><content:encoded><![CDATA[150亿美元大手笔！赛默飞世尔将收购CRO巨头PPD]]></content:encoded><pubDate>Thu, 15 Apr 2021 21:21:29 +0800</pubDate></item><item><title>2021太湖湾生命健康未来大会丨专家阵容</title><link>https://mp.weixin.qq.com/s/Z5XGx43PkcOrD0lv6seogg</link><description></description><content:encoded><![CDATA[2021太湖湾生命健康未来大会丨专家阵容]]></content:encoded><pubDate>Wed, 14 Apr 2021 23:56:32 +0800</pubDate></item><item><title>龙沙与君实生物签署战略合作备忘录，全面加速生物药开发与生产进程</title><link>https://mp.weixin.qq.com/s/Y0Sz-g9bxNw3tdhKpauKhg</link><description></description><content:encoded><![CDATA[龙沙与君实生物签署战略合作备忘录，全面加速生物药开发与生产进程]]></content:encoded><pubDate>Wed, 14 Apr 2021 23:56:32 +0800</pubDate></item><item><title>用于低资源分子优化的元学习</title><link>https://mp.weixin.qq.com/s/PsDWIMcqBCWfIXELpcXYOw</link><description></description><content:encoded><![CDATA[用于低资源分子优化的元学习]]></content:encoded><pubDate>Wed, 14 Apr 2021 23:56:32 +0800</pubDate></item><item><title>植德写意丨药物警戒：药物全生命周期的风险监管制度（上）</title><link>https://mp.weixin.qq.com/s/TOtG17luXGWHVDNjHdD8Jg</link><description></description><content:encoded><![CDATA[植德写意丨药物警戒：药物全生命周期的风险监管制度（上）]]></content:encoded><pubDate>Wed, 14 Apr 2021 23:56:32 +0800</pubDate></item><item><title>放疗2.0：局部电场疗法或延长二线转移肺癌OS</title><link>https://mp.weixin.qq.com/s/z_aGpJNQfQPNg6eSKHDXgw</link><description></description><content:encoded><![CDATA[放疗2.0：局部电场疗法或延长二线转移肺癌OS]]></content:encoded><pubDate>Wed, 14 Apr 2021 23:56:32 +0800</pubDate></item><item><title>写意讨论丨迎接药物集采新政下商业化生产新时代的到来</title><link>https://mp.weixin.qq.com/s/-SmSMsImJVInpbMfbXFhXg</link><description></description><content:encoded><![CDATA[写意讨论丨迎接药物集采新政下商业化生产新时代的到来]]></content:encoded><pubDate>Tue, 13 Apr 2021 23:05:16 +0800</pubDate></item><item><title>PD-1进医保、出海，国产PD-L1队列还有看点吗？</title><link>https://mp.weixin.qq.com/s/Q0lrxIsdrrgT9e8fmpoYBA</link><description></description><content:encoded><![CDATA[PD-1进医保、出海，国产PD-L1队列还有看点吗？]]></content:encoded><pubDate>Tue, 13 Apr 2021 23:05:16 +0800</pubDate></item></channel></rss>